ABOUT EVENT

Welcome to the 9th CDD for Biologics Summit
The Must-Attend Meeting!

As computational methods continue to evolve, advanced techniques are significantly enhancing biologics drug discovery and development. To fully harness this potential, computational tools need to become more robust and better integrated into the overall drug discovery pipeline, ensuring their impact in translating initial hits into preclinical and clinical stages. Making now a more important than ever to stay ahead of the curve on the latest advancements and methodologies shaping the future of biologics development.

The 9th Computational Drug Development for Biologics Summit was the only industry-focused event dedicated to leveraging these advancements to guide decision-making and streamline the biologic drug discovery process. Join us for this unique opportunity to explore the full potential of computational tools across the biologics development pipeline and learn how to integrate innovative methodologies that expedite the discovery and development process.

With fresh new content covering computational and structural biology, along with protein and antibody engineering, here’s what attendees enjoyed in 2024:

32782 - 8th Computational Drug Development for Biologics Summit favicon
32782 - 8th Computational Drug Development for Biologics Summit favicon
32782 - 8th Computational Drug Development for Biologics Summit favicon
32782 - 8th Computational Drug Development for Biologics Summit favicon
32782 - 8th Computational Drug Development for Biologics Summit favicon

Hear the latest cutting-edge work from the Baker Lab, renowned for its ground-breaking work in protein design and engineering

Cut through the hype and hear real-world case studies where AI has generated novel biologics with Absci & AI Proteins

Discover how to better integrate computational tools into the discovery pipeline to harness their potential to translate initial hits into clinical and preclinical stages with Boehringer Ingelheim

Strategies for streamlining and automating data collection to enable continuous machine learning AbbVie & Takeda

Uncover how computational tools can improve mechanistic understanding of degradation and higher order structural characterization of biologics with Bristol Myers Squibb

Who Was There?

Seniority Graph
Companies Graph